A cryptic BCR-PDGFRB fusion resulting in a chronic myeloid neoplasm with monocytosis and eosinophilia: Anovelfindingwithtreatmentimplications

7Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

RNA-seq was used to identify the partner gene and confirm the presence of a BCR-PDGFRB fusion. Identification of this fusion product resulted in successful treatment and long-term remission of this myeloid neoplasm. Based on our results, we suggest that despite current WHO recommendations, screening for PDGFRB rearrangement in cases of leukocytosis with eosinophilia and no other etiologic explanation is necessary, even if the karyotype is normal.

Cite

CITATION STYLE

APA

Gupta, S. K., Jain, N., Tang, G., Futreal, A., Wang, S. A., Khoury, J. D., … Loghavi, S. (2020). A cryptic BCR-PDGFRB fusion resulting in a chronic myeloid neoplasm with monocytosis and eosinophilia: Anovelfindingwithtreatmentimplications. JNCCN Journal of the National Comprehensive Cancer Network, 18(10), 1300–1304. https://doi.org/10.6004/jnccn.2020.7573

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free